These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23032552)

  • 1. Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.
    Statland JM; Bundy BN; Wang Y; Rayan DR; Trivedi JR; Sansone VA; Salajegheh MK; Venance SL; Ciafaloni E; Matthews E; Meola G; Herbelin L; Griggs RC; Barohn RJ; Hanna MG;
    JAMA; 2012 Oct; 308(13):1357-65. PubMed ID: 23032552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials.
    Stunnenberg BC; Raaphorst J; Groenewoud HM; Statland JM; Griggs RC; Woertman W; Stegeman DF; Timmermans J; Trivedi J; Matthews E; Saris CGJ; Schouwenberg BJ; Drost G; van Engelen BGM; van der Wilt GJ
    JAMA; 2018 Dec; 320(22):2344-2353. PubMed ID: 30535218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.
    Vicart S; Franques J; Bouhour F; Magot A; Péréon Y; Sacconi S; Nadaj-Pakleza A; Behin A; Zahr N; Hézode M; Fournier E; Payan C; Lacomblez L; Fontaine B
    Neuromuscul Disord; 2021 Nov; 31(11):1124-1135. PubMed ID: 34702654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
    Logigian EL; Martens WB; Moxley RT; McDermott MP; Dilek N; Wiegner AW; Pearson AT; Barbieri CA; Annis CL; Thornton CA; Moxley RT
    Neurology; 2010 May; 74(18):1441-8. PubMed ID: 20439846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.
    Stunnenberg BC; Woertman W; Raaphorst J; Statland JM; Griggs RC; Timmermans J; Saris CG; Schouwenberg BJ; Groenewoud HM; Stegeman DF; van Engelen BG; Drost G; van der Wilt GJ
    BMC Neurol; 2015 Mar; 15():43. PubMed ID: 25880166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel.
    Chapman AM; Schurer M; Weijers L; Omar A; Lee H; Weidenfeller AZ; Ellis C; Sonecha S; Schneider-Gold C
    BMC Neurol; 2021 Dec; 21(1):467. PubMed ID: 34852780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study.
    Andersen G; Hedermann G; Witting N; Duno M; Andersen H; Vissing J
    Brain; 2017 Sep; 140(9):2295-2305. PubMed ID: 29050397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.
    Trivedi JR; Bundy B; Statland J; Salajegheh M; Rayan DR; Venance SL; Wang Y; Fialho D; Matthews E; Cleland J; Gorham N; Herbelin L; Cannon S; Amato A; Griggs RC; Hanna MG; Barohn RJ;
    Brain; 2013 Jul; 136(Pt 7):2189-200. PubMed ID: 23771340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS).
    Yamada S; Hashizume A; Hijikata Y; Inagaki T; Ito D; Kinoshita F; Nakatochi M; Kobayashi Y; Hirakawa A; Nakamura T; Katsuno M
    BMJ Open; 2018 Sep; 8(9):e023041. PubMed ID: 30206090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial.
    Wu CL; Agarwal S; Tella PK; Klick B; Clark MR; Haythornthwaite JA; Max MB; Raja SN
    Anesthesiology; 2008 Aug; 109(2):289-96. PubMed ID: 18648238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial.
    Kemper CA; Kent G; Burton S; Deresinski SC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):367-72. PubMed ID: 9833745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interactive voice response diary for patients with non-dystrophic myotonia.
    Statland JM; Wang Y; Richesson R; Bundy B; Herbelin L; Gomes J; Trivedi J; Venance S; Amato A; Hanna M; Griggs R; Barohn RJ;
    Muscle Nerve; 2011 Jul; 44(1):30-5. PubMed ID: 21674518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Heatwole C; Luebbe E; Rosero S; Eichinger K; Martens W; Hilbert J; Dekdebrun J; Dilek N; Zizzi C; Johnson N; Puwanant A; Tawil R; Schifitto G; Beck CA; Richeson JF; Zareba W; Thornton C; McDermott MP; Moxley R
    Neurology; 2021 Jan; 96(2):e228-e240. PubMed ID: 33046619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of myotonia with antiarrhythmic drugs.
    Kwieciński H; Ryniewicz B; Ostrzycki A
    Acta Neurol Scand; 1992 Oct; 86(4):371-5. PubMed ID: 1455983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral mexiletine on capsaicin-induced allodynia and hyperalgesia: a double-blind, placebo-controlled, crossover study.
    Ando K; Wallace MS; Braun J; Schulteis G
    Reg Anesth Pain Med; 2000; 25(5):468-74. PubMed ID: 11009231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study.
    Wallace MS; Magnuson S; Ridgeway B
    Reg Anesth Pain Med; 2000; 25(5):459-67. PubMed ID: 11009230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy.
    Wright JM; Oki JC; Graves L
    Ann Pharmacother; 1997 Jan; 31(1):29-34. PubMed ID: 8997461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Based Price Calculation of Mexiletine for Nondystrophic Myotonia.
    van den Berg S; van der Wel V; de Visser SJ; Stunnenberg BC; Timmers L; van der Ree MH; Postema PG; Hollak CEM
    Value Health; 2021 Jul; 24(7):925-929. PubMed ID: 34243835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexiletine for treatment of myotonia: a trial triumph for rare disease networks.
    Hoffman EP; Kaminski HJ
    JAMA; 2012 Oct; 308(13):1377-8. PubMed ID: 23032555
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia.
    Desaphy JF; Camerino DC; Tortorella V; De Luca A
    Neuromuscul Disord; 1999 May; 9(3):182-9. PubMed ID: 10382914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.